Literature DB >> 18804472

Regulated catalysis of extracellular nucleotides by vascular CD39/ENTPD1 is required for liver regeneration.

Guido Beldi1, Yan Wu, Xiaofeng Sun, Masato Imai, Keiichi Enjyoji, Eva Csizmadia, Daniel Candinas, Laurie Erb, Simon C Robson.   

Abstract

BACKGROUND & AIMS: Little is known about how endothelial cells respond to injury, regulate hepatocyte turnover and reconstitute the hepatic vasculature. We aimed to determine the effects of the vascular ectonucleotidase CD39 on sinusoidal endothelial cell responses following partial hepatectomy and to dissect purinergic and growth factor interactions in this model.
METHODS: Parameters of liver injury and regeneration, as well as the kinetics of hepatocellular and sinusoidal endothelial cell proliferation, were assessed following partial hepatectomy in mice that do not express CD39, that do not express ATP/UTP receptor P2Y2, and in controls. The effects of extracellular ATP on vascular endothelial growth factor (VEGF), hepatocyte growth factor (HGF), and interleukin-6 responses were determined in vivo and in vitro. Phosphorylation of the endothelial VEGF receptor in response to extracellular nucleotides and growth factors was assessed in vitro.
RESULTS: After partial hepatectomy, expression of the vascular ectonucleotidase CD39 increased on sinusoidal endothelial cells. Targeted disruption of CD39 impaired hepatocellular regeneration, reduced angiogenesis, and increased hepatic injury, resulting in pronounced vascular endothelial apoptosis, and decreased survival. Decreased HGF release by sinusoidal endothelial cells, despite high levels of VEGF, reduced paracrine stimulation of hepatocytes. Failure of VEGF receptor-2/KDR transactivation by extracellular nucleotides on CD39-null endothelial cells was associated with P2Y2 receptor desensitization.
CONCLUSIONS: Regulated phosphohydrolysis of extracellular nucleotides by CD39 coordinates both hepatocyte and endothelial cell proliferation following partial hepatectomy. Lack of CD39 activity is associated with decreased hepatic regeneration and failure of vascular reconstitution.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804472      PMCID: PMC2900919          DOI: 10.1053/j.gastro.2008.07.025

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  23 in total

1.  CD39 modulates endothelial cell activation and apoptosis.

Authors:  C Goepfert; M Imai; S Brouard; E Csizmadia; E Kaczmarek; S C Robson
Journal:  Mol Med       Date:  2000-07       Impact factor: 6.354

Review 2.  Liver regeneration.

Authors:  Nelson Fausto; Jean S Campbell; Kimberly J Riehle
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

3.  Spatiotemporal expression of angiogenesis growth factor receptors during the revascularization of regenerating rat liver.

Authors:  M A Ross; C M Sander; T B Kleeb; S C Watkins; D B Stolz
Journal:  Hepatology       Date:  2001-12       Impact factor: 17.425

4.  Regenerative capacity of individual liver lobes in the microsurgical mouse model.

Authors:  Daniel Inderbitzin; Peter Studer; Daniel Sidler; Guido Beldi; Valentin Djonov; Adrian Keogh; Daniel Candinas
Journal:  Microsurgery       Date:  2006       Impact factor: 2.425

5.  Platelet-derived serotonin mediates liver regeneration.

Authors:  Mickael Lesurtel; Rolf Graf; Boris Aleil; Diego J Walther; Yinghua Tian; Wolfram Jochum; Christian Gachet; Michael Bader; Pierre-Alain Clavien
Journal:  Science       Date:  2006-04-07       Impact factor: 47.728

6.  Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.

Authors:  K Enjyoji; J Sévigny; Y Lin; P S Frenette; P D Christie; J S Esch; M Imai; J M Edelberg; H Rayburn; M Lech; D L Beeler; E Csizmadia; D D Wagner; S C Robson; R D Rosenberg
Journal:  Nat Med       Date:  1999-09       Impact factor: 53.440

7.  Nucleotide-regulated calcium signaling in lung fibroblasts and epithelial cells from normal and P2Y(2) receptor (-/-) mice.

Authors:  L Homolya; W C Watt; E R Lazarowski; B H Koller; R C Boucher
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

Review 8.  Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction.

Authors:  Y Sato; S Kanno; N Oda; M Abe; M Ito; K Shitara; M Shibuya
Journal:  Ann N Y Acad Sci       Date:  2000-05       Impact factor: 5.691

9.  Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice.

Authors:  Shaun W Jackson; Tomokazu Hoshi; Yan Wu; Xiaofeng Sun; Keiichi Enjyoji; Eva Cszimadia; Christian Sundberg; Simon C Robson
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

10.  Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.

Authors:  Guido Beldi; Yan Wu; Yara Banz; Michael Nowak; Lindsay Miller; Keiichi Enjyoji; Arvand Haschemi; Gennady G Yegutkin; Daniel Candinas; Mark Exley; Simon C Robson
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

View more
  39 in total

1.  Role of purinergic P2X receptors in the control of liver homeostasis.

Authors:  Michel Fausther; Emmanuel Gonzales; Jonathan A Dranoff
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012-01-11

2.  Coexpression of ecto-5'-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver.

Authors:  Michel Fausther; Joanna Lecka; Elwy Soliman; Gilles Kauffenstein; Julie Pelletier; Nina Sheung; Jonathan A Dranoff; Jean Sévigny
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-01       Impact factor: 4.052

Review 3.  Biological implications of extracellular adenosine in hepatic ischemia and reperfusion injury.

Authors:  M A Zimmerman; I Kam; H Eltzschig; A Grenz
Journal:  Am J Transplant       Date:  2013-08-07       Impact factor: 8.086

Review 4.  Introduction to adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson
Journal:  Handb Exp Pharmacol       Date:  2009

5.  SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.

Authors:  Melanie L Hart; Iris C Gorzolla; Jens Schittenhelm; Simon C Robson; Holger K Eltzschig
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

6.  Distinct roles of ecto-nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) in liver regeneration and fibrosis.

Authors:  Linda Feldbrügge; Z Gordon Jiang; Eva Csizmadia; Shuji Mitsuhashi; Stephanie Tran; Eric U Yee; Sonja Rothweiler; Kahini A Vaid; Jean Sévigny; Moritz Schmelzle; Yury V Popov; Simon C Robson
Journal:  Purinergic Signal       Date:  2017-11-13       Impact factor: 3.765

7.  P2X7 receptor-mediated purinergic signaling promotes liver injury in acetaminophen hepatotoxicity in mice.

Authors:  Rafaz Hoque; Muhammed Adnan Sohail; Steven Salhanick; Ahsan F Malik; Ayaz Ghani; Simon C Robson; Wajahat Z Mehal
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-01       Impact factor: 4.052

8.  Expression of mediators of purinergic signaling in human liver cell lines.

Authors:  Jessica R Goree; Elise G Lavoie; Michel Fausther; Jonathan A Dranoff
Journal:  Purinergic Signal       Date:  2014-09-07       Impact factor: 3.765

9.  Tob1 is a constitutively expressed repressor of liver regeneration.

Authors:  Karen J Ho; Nhue L Do; Hasan H Otu; Martin J Dib; Xianghui Ren; Keiichi Enjyoji; Simon C Robson; Ernest F Terwilliger; Seth J Karp
Journal:  J Exp Med       Date:  2010-05-31       Impact factor: 14.307

10.  Hepatic and seric levels of purines in rats experimentally infected by Fasciola hepatica.

Authors:  Matheus D Baldissera; Ricardo E Mendes; Pedro H Doleski; Nathieli B Bottari; Emerson A Casali; Cesar Eduardo Jacintho Moritz; Valesca V Cardoso; Luan C Henker; Ricardo Christ; Fernanda A Stedille; Lenita M Stefani; Aleksandro S Da Silva
Journal:  Parasitol Res       Date:  2016-03-12       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.